SCYL3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.076800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.843400E-01
Normal-vs-Stage2
8.371600E-01
Normal-vs-Stage3
1.386070E-02
Normal-vs-Stage4
3.282600E-01
Stage1-vs-Stage2
4.649200E-01
Stage1-vs-Stage3
9.024500E-02
Stage1-vs-Stage4
6.140000E-01
Stage2-vs-Stage3
5.535900E-02
Stage2-vs-Stage4
3.274400E-02
Stage3-vs-Stage4
3.921800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.529400E-01
Normal-vs-AfricanAmerican
3.755000E-01
Normal-vs-Asian
8.434600E-01
Caucasian-vs-AfricanAmerican
1.069630E-01
Caucasian-vs-Asian
3.033200E-01
AfricanAmerican-vs-Asian
5.405200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.529600E-01
Normal-vs-Female
7.562400E-01
Male-vs-Female
6.456400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.424400E-01
Normal-vs-Age(41-60Yrs)
8.780600E-01
Normal-vs-Age(61-80Yrs)
7.444000E-01
Normal-vs-Age(81-100Yrs)
9.098800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.197400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.359200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.761000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.328400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.782200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.173000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.113200E-01
Normal-vs-Daily Drinker
1.493220E-01
Normal-vs-Weekly Drinker
8.351400E-01
Normal-vs-Occasional Drinker
9.022000E-01
Normal-vs-Social Drinker
6.854400E-01
Non Drinker-vs-Daily Drinker
6.716200E-02
Non Drinker-vs-Weekly Drinker
9.847200E-01
Non Drinker-vs-Occasional Drinker
5.744600E-01
Non Drinker-vs-Social Drinker
9.082200E-01
Daily Drinker-vs-Weekly Drinker
3.150600E-01
Daily Drinker-vs-Occasional Drinker
1.639840E-02
Daily Drinker-vs-Social Drinker
5.412000E-02
Weekly Drinker-vs-Occasional Drinker
7.625600E-01
Weekly Drinker-vs-Social Drinker
9.601600E-01
Occasional Drinker-vs-Social Drinker
6.544800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.208000E-02
Normal-vs-Grade 2
1.204360E-02
Normal-vs-Grade 3
2.160500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.049200E-01
Grade 1-vs-Grade 3
3.179800E-01
Grade 1-vs-Grade 4
6.208000E-02
Grade 2-vs-Grade 3
3.890800E-01
Grade 2-vs-Grade 4
1.204360E-02
Grade 3-vs-Grade 4
2.160500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.527800E-01
Normal-vs-NonDiabetic
6.940600E-01
Diabetic-vs-NonDiabetic
3.202000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.923800E-01
Normal-vs-NoPancreatitis
6.942000E-01
Pancreatitis-vs-NoPancreatitis
4.589400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.685000E-01
Normal-vs-N1
7.180600E-01
N0-vs-N1
2.546600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.766600E-01
Normal-vs-TP53-NonMutant
7.236800E-01
TP53-Mutant-vs-TP53-NonMutant
9.520000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
